These findings suggest that TRPM2 plays a crucial role in tumor growth and survival, and targeting TRPM2-L could be a potential strategy to reduce tumor growth and enhance chemotherapy efficacy by modulating HIF-1/2 and mitochondrial function [42]. The gene discussed is TRPM2; the disease is neoplasm.